Stem/progenitor cells isolated from human dental follicles differentiate into osteogenic cells. To investigate factors associated with osteogenic differentiation/mineralization in human dental follicle cells (hDFCs), we performed gene expression profiling of hDFCs during osteogenic differentiation. Cyclooxygenase(COX)-1 and -2 were up-regulated in hDFCs cultured in osteogenic induction medium(OIM)compared to growth medium(GM). Prostaglandin E 2 (PGE 2 ), which is the most studied prostanoid derived from arachidonic acid through the actions of COXs, may regulate bone metabolism. All PGE 2 E-type prostanoid receptors(EP), EP1-EP4, were expressed in hDFCs. Real-time PCR showed that the expression of EP2 and EP4 was increased in hDFCs cultured in OIM and GM at days 10 and 17 compared to day 0. We investigated the action of PGE 2 in osteogenic differentiation using hDFCs. PGE 2 decreased gene expression levels of osterix and alkaline phosphatase, which are factors associated with osteogenic differentiation. PGE 2 elicited inhibitory action on matrix mineralization of hDFCs as seen with alizarin red S staining. These findings suggest that PGE 2 may inhibit osteogenic differentiation/mineralization of stem/progenitor cells.
Introduction
Neural crest cells, a specific population of vertebrate cells that originate in the dorsal neural tube, form a variety of tissues including the dorsal root ganglia, peripheral nerves, and craniofacial bone(1-3). The dental follicle, which is an ectomesenchymal tissue derived from the neural crest that surrounds the tooth germ, contains progenitor cells and/or stem cells. Human dental follicle cells (hDFCs) have a capacity to commit to differentiate into multiple cell lineages such as osteoblastic and adipogenic cells (4, 5) . hDFCs are a major source of stem cells in adults, as they can be easily got during the extraction of impacted teeth. We previously reported that hDFCs can differentiate into osteogenic cells in osteogenic induction medium(OIM)without dexamethasone (6) , which has various biological effects such as anti-inflammatory properties. In addition, we compared the gene expression profiles between mesenchymal stem cells (MSCs)from human bone marrow(hMSCs)and hDFCs to assess whether hDFCs are a useful cell source for applications in clinical tissue regeneration (7) . The expression of MSC markers and growth factor receptors is similar in hDFCs and hMSCs, whereas hDFCs highly express LIM (acronym of Lin-11, lsl-1, Mec-3) homeobox 8, which is associated with development of the palatal mesenchyme and tooth germ (7) .
Prostaglandins, which are lipid metabolites derived from arachidonic acid through the actions of cyclooxygenase (COX)-1 and -2, play an important role in bone formation and inflammatory processes. Prostaglandin E 2 (PGE 2 ) is abundantly expressed in bone and plays important roles in skeletal metabolism (8) . PGE 2 increases bone marrow mineralized nodule formation when administered systemically, suggesting that PGE 2 increases the number of committed progenitors (9) . In contrast, PGE 2 effectively suppresses MSCs during bone marrow-mediated matrix The aim of this study was to investigate the effect of PGE 2 during osteogenic differentiation using hDFCs.
Materials and Methods
Isolation and culture of hDFCs hDFCs were obtained using according to a previously reported method (5 
Microarray analysis
Gene expression profiling was performed using SurePrint G3 Human GE microarray 8×60k(Agilent, Santa Clara, CA)
according to the manufacturerʼs protocol. Briefly, cRNA labelled with Gy3 was generated from 100 ng total RNA using the Low Input Quick Amp Labeling kit, one-colour Table 1 . Gene expression levels were calculated using the C T method with normalization to GAPDH(11).
PCR fragments were electrophoresed on 1.5% agarose gels, followed by staining with Midori Green Direct (NIPPON Genetics, Tokyo, Japan) and examination of fragment sizes.
Statistical analysis
Data are shown as mean values SD, One-way ANOVA and Two-way ANOVA were used to analyze differences.
Results

COX gene expression
We performed microarray analysis to determine the genes regulated in hDFCs during osteogenic differentiation (6) . As shown in Table 2 , the gene expression of COX-1 and COX-2 was increased in hDFCs cultured in OIM at day 17 compared to cells cultured in GM on days 0 and 17.
We examined the gene expression of COX-1 and -2 in hDFCs during osteogenic differentiation using real-time PCR. COX-1 and COX-2 expression was significantly increased in hDFCs cultured in OIM compared to GM on day 17 (Fig. 1) . The expression of COXs was not different between cultures grown in OIM and GM on day 3 or day 10.
PGE 2 receptor gene expression
To examine the functional effects of PGE 2 on hDFCs, we analyzed the expression of PGE 2 receptors, EP1-4, in hDFCs using RT-PCR (Fig. 2) . hDFCs before osteogenic differentiation was not induced expressed all EPs (Fig. 2) . The expression of EP4 was up-regulated in hDFCs on day 17 compared to day 0 as seen with microarray analysis (Table   3) . We confirmed the expression of EPs in hDFCs during osteogenic differentiation using real-time PCR (Fig. 3) . The expression of EP4 was significantly increased in hDFCs cultured in OIM on day 10 and 17 compared to day 0 whereas the expression was also significantly increased in hDFCs cultured in GM. The expression of EP4 was slightly increased in OIM than GM on day 10 and 17. The expression of EP2 was significantly increased in hDFCs in a time-dependent manner during osteogenic differentiation. The expression of EP2 was increased in GM culture in a time-dependent manner although the increase level was Table 2 . COX DNA Microarray Fig. 2 . The expression of PGE 2 receptors in human dental follicle cells. mRNA levels of E-type prostanoid receptors(EP1, EP2, EP3, and EP4), in hDFCs were analyzed using RT-PCR. The PCR products were electrophoresed through an agarose gel. Values represent means SD of the results from three independent experiments. *P < 0.05 ,**P < 0.01 compared to cells cultured GM at the indicated time points. hDFC-2)was also weak following treatment with PGE 2 (Fig.   4 ). COXs are enzymes that convert arachidonic acid into Prostaglandin G2 and then into Prostaglandin H2 (12) .
COX-1 is often referred to asʠconstitutive,ʡbecause it is expressed at stable levels in cells, in contrast to COX-2, which is expressed at low levels until a stimulusʠinducesʡ expression (12) . COX-1 expression is induced in stromal cells and osteoblasts by several stimuli, although the induced level of COX-1 is low compared to that of COX-2(13). In this study, the expression of COX-1 and -2 was up-regulated in hDFCs during late stages of osteogenic differentiation. Therefore, prostanoids derived from arachidonic acid through the actions of COXs may be associated with mineralization of hDFCs. PGE 2 , which is the most well-studied prostanoid derived from arachidonic acid through the actions of COXs, may play an important role in bone remodeling under physiological and pathological conditions. PGE 2 increases bone formation and bone mass in in vivo experiments using rats (14) . Local delivery of PGE 2 enhances bone formation at the cortical bone graft junction (15) . The pro-osteogenic effect of PGE 2 has been further substantiated by findings from numerous in vitro studies using murine-or rat-derived MSCs and osteoblasts (16, 17) . The ability of PGE 2 to enhance bone formation has largely been attributed to its stimulatory effects on MSC differentiation (16, 18) . In contrast, findings from in vitro studies utilizing hMSCs derived from bone marrow and adipose tissue suggest that PGE 2 may also have a negative influence on osteogenesis (10, 19) . Our findings showed that continuous treatment with showing that bone formation is enhanced by a selective EP agonists (24) and also that PGE 2 -mediated bone formation is abolished only in EP2 or EP4 knockout mice (25, 26) . It also suggested that PGE 2 mediated its effects through EP2 and EP4 in inhibiting matrix mineralization of hMSCs derived from bone marrow (10) . The expression of EP2 was increased in hMSCs on day 7 and 14 during osteogenic differentiation. The expression of EP4 was increased in these cells on day 14 whereas decreased on day 7. However, despite identifying dexamethasone as a potent stimulator of EP2 expression, and, to a lesser extent, EP4 expression, the response of hMSCs to PGE 2 was independent of dexamethasone. In addition, they suggested that treatment of hMSCs with EP4 siRNA proved more effective than EP2 siRNA in rescuing matrix mineralization by hMSCs treated with PGE 2 (10) . In our study, the expression of EP2 and EP4 was increased in hDFCs toward the late stage of osteoblast differentiation/mineralization, although hDFCs were cultured without dexamethasone. On the other hand, the up-regulation of EP2 and EP4 were earlier than those of COXs in hDFCs. Because the COXs were expressed in hDFCs of early stage for osteoblast differentiation/mineralization, PGE 2 may be produced in hDFCs constitutively.
Future investigations should examine the PGE 2 production in hDFCs and the effect of endogenous and exogenous PGE 2 on osteogenic differentiation/mineralization of hDFCs. In addition, comparisons of the effects of EP1-EP4 should be studied on osteoblast differentiation/mineralization of hDFCs using selective agonists and/or antagonists, or receptor siRNAs of these receptors.
In conclusion, we investigated the effect of PGE 2 on osteogenic differentiation and/or mineralization using hDFCs. Our data suggested that PGE 2 inhibits osteoblast differentiation/mineralization of hDFCs. These findings provide important insight into methods to control stem/progenitor cell lineage commitment and may increase understanding of the role of PGE 2 in physiological and pathological conditions.
Conflict of Interest
